← Open Payments lookup

TEMITOPE ADEDAPO: Open Payments

NPI 1932821022 · GREENBELT, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$454 in 26 payments from 7 companies in 2025. Trend: 2023 $53 · 2024 $379 · 2025 $454

Food & beverage: $454
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.12$143
ABBVIE INC.6$124
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$69
Neurocrine BioSciences, Inc.2$45
Vanda Pharmaceuticals Inc.1$30
Otsuka America Pharmaceutical, Inc.1$23
TMS NeuroHealth Centers Inc.1$21

Products named: Qelbree, VRAYLAR, CAPLYTA, INGREZZA, FANAPT, REXULTI, TMS NeuroHealth Centers Inc..

Industry payments across MD — which companies pay providers there.